Risk of brain clots higher with COVID than vaccine, study suggestsA study has suggested that the risk of getting a serious brain clot is eight to 10 times Share XRisk of brain clots higher with COVID than vaccine, study suggestshttps://pharmaphorum.com/news/risk-of-brain-clots-higher-with-covid-than-vaccine-study-suggests/
Czech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shotsThe Czech Republic wants to buy around 2.4 million doses of the AstraZeneca/Oxford University vaccine ditched by Denmark, Share XCzech Republic swoops for Denmark’s 2.4m unwanted AZ COVID shotshttps://pharmaphorum.com/news/czech-republic-swoops-for-denmarks-2-4m-unwanted-az-covid-shots/
UK will offer under-30s alternative to AZ’s COVID jabThe UK drugs regulator has said people aged under 30 should be offered an alternative to the AstraZeneca Share XUK will offer under-30s alternative to AZ’s COVID jabhttps://pharmaphorum.com/news/uk-will-offer-under-30s-alternative-to-azs-covid-jab/
Paediatric trial of AZ COVID jab ‘halted as a precaution’Oxford University has suspended a clinical trial of its AstraZeneca-partnered COVID-19 vaccine in children and adolescents while a Share XPaediatric trial of AZ COVID jab ‘halted as a precaution’https://pharmaphorum.com/news/paediatric-trial-of-az-covid-jab-halted-as-a-precaution/
Safety study pushes back phase 3 trial of Newron’s schizophrenia drugSwitzerland’s neurology specialist Newron must hold off starting a phase 3 study of its schizophrenia drug evenamide to Share XSafety study pushes back phase 3 trial of Newron’s schizophrenia drughttps://pharmaphorum.com/news/safety-trial-pushes-back-phase-3-trial-of-newrons-schizophrenia-drug/
EMA backs safety of AZ COVID-19 jab in all age groupsThe head of the EMA has reiterated that there is no evidence to limit the use of AstraZeneca’s Share XEMA backs safety of AZ COVID-19 jab in all age groupshttps://pharmaphorum.com/news/ema-backs-safety-of-az-covid-19-jab-in-all-age-groups/
AZ issues revised efficacy figures for COVID-19 shotAstraZeneca has issued revised efficacy figures from the US trial of its COVID-19 vaccine following a complaint from Share XAZ issues revised efficacy figures for COVID-19 shothttps://pharmaphorum.com/news/az-issues-revised-efficacy-figures-for-covid-19-shot/
EMA review finds AZ COVID-19 vaccine “safe and effective”An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall Share XEMA review finds AZ COVID-19 vaccine “safe and effective”https://pharmaphorum.com/news/ema-review-finds-az-covid-19-vaccine-safe-and-effective/
WHO backs safety of AstraZeneca vaccine ahead of key EU meetingThe World Health Organization has backed the safety of the Oxford University/AstraZeneca vaccine ahead of a key announcement Share XWHO backs safety of AstraZeneca vaccine ahead of key EU meetinghttps://pharmaphorum.com/news/who-backs-safety-of-astrazeneca-vaccine-ahead-of-key-eu-meeting/
